About Olivo Labs
Olivo Labs is a Healthcare company based in Cambridge (United States) founded in 2015, and was acquired by Shiseido in January 2018. Products for skin-related medical conditions are developed using tunable materials. Its chief executive, as recorded, is Masahiko Uotani. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Dressing. Its competitors include Avidity Biosciences, Revance Therapeutics and Sutro Biopharma; 3 of its 3 listed competitors have raised funding.
Company details
Olivo Labs was founded in 2015 in Cambridge, United States, within the biotechnology sector. Products targeting skin-related medical conditions are developed through a platform technology based on tunable polysiloxane materials. These materials are engineered to replicate youthful skin properties, such as elasticity, breathability, invisibility, water resistance, and protection. Operations focus on medical applications for dermatological needs in a research-driven environment.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website olivolabs.com
- Social LinkedIn X
- Acquired by Shiseido (Jan 2018)
Investors in Olivo Labs
Olivo Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shiseido.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Skincare, makeup, and suncare products are offered by Shiseido. | 1872 | shiseido.com | Tokyo, Japan |
Investor details for Olivo Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Olivo Labs
1 people are tracked at Olivo Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Masahiko Uotani | CEO | Leadership |
Complete people profiles for Olivo Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Olivo Labs
2 dated milestones of Olivo Labs across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Olivo Labs is founded.
- Exit Acquired by Shiseido.
Competitors of Olivo Labs
Olivo Labs has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Revance Therapeutics and Sutro Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed competitors of Olivo Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Olivo Labs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Olivo Labs
Complete news archive for Olivo Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Olivo Labs
Olivo Labs was founded in 2015.
Olivo Labs is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Masahiko Uotani is the CEO of Olivo Labs, as recorded in our data.
Olivo Labs was founded in 2015 in Cambridge, United States, within the biotechnology sector. Products targeting skin-related medical conditions are developed through a platform technology based on tunable polysiloxane materials. These materials are engineered to replicate youthful skin properties, such as elasticity, breathability, invisibility, water resistance, and protection. Operations focus on medical applications for dermatological needs in a research-driven environment.
Olivo Labs's top competitors include Revance Therapeutics, Sutro Biopharma and Avidity Biosciences.
Olivo Labs has 1 investor. Key investors include Shiseido.
Yes. Olivo Labs was acquired by Shiseido in January 2018.